not even a factor, IMO. With WL, I valued galanin at $0. Without them, it's worth maybe $1 million? Just recently poured over the 10-K, and the WL deal stood out as one heck of a low-comittment project.
look forward to seeing the entire release.......
"The Company's fourth collaboration, the one with Warner-Lambert, is
focused on a family of receptors with respect to which the pharmacological data
suggesting a role for members of this family in physiological disorders was, at
the outset of the collaboration, considerably more speculative. As a result, the
Company's agreement with Warner-Lambert provides for a collaboration conducted
in two stages. In the first stage, the companies engage in a joint research
program designed to identify the role of members of the targeted receptor family
in a variety of disorders. During this stage, the companies fund their own
research efforts. It is not until the second stage, which will occur only if a
certain amount of scientific progress is made during the first stage, that
Warner-Lambert may become obligated to provide research funding to Synaptic." |
